Page last updated: 2024-08-23

cefmetazole and Far East Scarlet-like Fever

cefmetazole has been researched along with Far East Scarlet-like Fever in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fukuda, H; Hashimoto, T; Hashinaga, K; Hayashidani, H; Nureki, SI; Sakamoto, T; Shigemitsu, O; Takenaka, R1
Fukunaga, K; Kubo, M; Wada, N1

Reviews

1 review(s) available for cefmetazole and Far East Scarlet-like Fever

ArticleYear
Septic shock due to Yersinia pseudotuberculosis infection in an adult immunocompetent patient: a case report and literature review.
    BMC infectious diseases, 2021, Jan-07, Volume: 21, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Blood Culture; Cefmetazole; Ceftriaxone; Doripenem; Fever; Humans; Immunocompetence; Male; Pneumonia, Bacterial; Shock, Septic; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections

2021

Other Studies

1 other study(ies) available for cefmetazole and Far East Scarlet-like Fever

ArticleYear
[Two cases of Yersinia pseudotuberculosis infection in children].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1990, Volume: 64, Issue:11

    Topics: Age Factors; Cefmetazole; Child, Preschool; Humans; Immunity, Cellular; Infant; Male; Yersinia pseudotuberculosis Infections

1990